Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea.
Shim JS, Jin J, Kim SH, Lee T, Jang AS, Park CS, Jung JW, Kwon JW, Moon JY, Yang MS, Lee J, Choi JH, Shin YS, Kim HK, Kim S, Kim JH, Cho SH, Nam YH, Kim SH, Park SY, Hur GY, Kim SH, Park HK, Jin HJ, Lee JH, Park JW, Yoon HJ, Choi BW, Cho YJ, Kim MH, Kim TB; Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) Study Group. Shim JS, et al. World Allergy Organ J. 2022 Nov 20;15(12):100720. doi: 10.1016/j.waojou.2022.100720. eCollection 2022 Dec. World Allergy Organ J. 2022. PMID: 36438190 Free PMC article.
We investigated the real-world use of tiotropium in asthmatic adult patients in Korea and we identified predictors of positive response to tiotropium add-on. METHODS: We performed a multicenter, retrospective, cohort study using data from the Cohort for Reality …
We investigated the real-world use of tiotropium in asthmatic adult patients in Korea and we identified predictors of positive response to t …
A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.
Park SY, Kim S, Kim JH, Kim SH, Lee T, Yoon SY, Kim MH, Moon JY, Yang MS, Jung JW, Kim JH, Choi JH, Park CS, Kim S, Lee J, Kwon JW, Hur GY, Kim SH, Kim HK, Shin YS, Kim SH, Nam YH, Jang AS, Park SY, Kim TB; Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) Study Group. Park SY, et al. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1304-1311.e2. doi: 10.1016/j.jaip.2020.09.066. Epub 2020 Nov 9. J Allergy Clin Immunol Pract. 2021. PMID: 33184024 Clinical Trial.